cancer-patients / English

add

Figuring out who to screen could change the game. This discovery is getting us closer.

Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, it works very well in shrinking tumors and sending cancer into remission, an undetectable state of cancer. But that…

Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, researchers reported in a new study.

BioNTech SE (NASDAQ:BNTX) and Bristol Myers Squibb & Co. (NYSE:BMY) on Tuesday shared the first interim data from a global randomized Phase 2 trial of pumitamig (BNT327/BMS986545) plus chemotherapy for locally advanced/metastatic triple…

Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its burixafor combination in multiple myeloma.

The vaccine is meant for adult patients with inoperable or metastatic melanoma

The equipment uses headsets, and sometimes game controllers, to immerse patients in calming or educational environments, reducing pain, anxiety, and nausea during chemotherapy and improving understanding of treatments such as radiation…

A revolutionary immune therapy that uses the body's own defences to fight illness has cured patients with the blood cancer ­multiple myeloma - the first treatment to do so.

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for side effects. Now new research by Fox Chase Cancer Center physicians shows that these patients can safely be…

Researchers found a link between the hormone estrone and breast cancer deaths in postmenopausal women

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.

Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, part of the…

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate. Patients often relapse after receiving initial therapy, making it especially challenging for clinicians to keep this…

Almost two thirds of the patients involved in the study now remain disease free, researchers say

Seven out of 11 patients with incurable cancer who had the treatment appear to be cancer-free.

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.

Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.